Other Relevant Adverse Effects Additional side effects that may indirectly affect energy include: Fatigue (listed as a common adverse reaction for Wegovy) Decreased appetite (very common, often therapeutic but may lead to inadequate nutrition) Headache (reported in clinical trials) Dizziness (may be related to dehydration or blood pressure changes) Gallbladder problems (including gallstones, which may present with fatigue and abdominal pain) While these effects do not constitute direct sedation or drowsiness, their cumulative impact on physical well-being can manifest as reduced energy and increased tiredness
The ominous octet, which includes 8 key pathophysiologic defects found to be present in T2D, is illustrated in Figure 1
While the specific mechanism causing the effects on the gastrointestinal tract are not fully elucidated, studies suggest GLP-1 and its analogues likely exert effects on the vagus nerve and inhibit cholinergic neurotransmission in the gastrointestinal system to prevent movement of the intestine
INFORMATION WEGOVY FLEXTOUCH 0.5mg (ITALIAN) Key Features and Benefits Wegovy FlexTouch 0.5mg is the second step in the dose escalation plan of semaglutide therapy for chronic weight management
Injecting can also come with risks like pain and swelling at the injection site, infection or allergic reaction
Semaglutide vials need to be kept at a specific temperature to stay effective